Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade
about
Role of endothelin in cardiovascular diseaseEndothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in manEndothelin-1 regulates proliferative responses, both alone and synergistically with PDGF, in rat tracheal smooth muscle cellsDiabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERKLong-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.Obesity and atrial fibrillation.Endothelin receptor antagonists in cardiology clinical trials.Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling.Endothelin-1: a multifunctional molecule in cancer.Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions.Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.Growth hormone, acromegaly, and heart failure: an intricate triangulation.Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese PopulationBosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis.Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial HypertensionActivation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1.The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.Pulmonary hypertension caused by sarcoidosisPleiotropic effects of statin therapy: molecular mechanisms and clinical results.The role of shear stress on ET-1, KLF2, and NOS-3 expression in the developing cardiovascular system of chicken embryos in a venous ligation model.Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension.Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension.Combination therapy in pulmonary arterial hypertension: do we have the right strategy?Statins and vein graft failure in coronary bypass surgery.The relationship of stress and blood pressure effectors.Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.Coupling of endothelin receptors to the ERK/MAP kinase pathway. Roles of palmitoylation and G(alpha)q.Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarctionEndothelial dysfunction: the role and impact of the renin-angiotensin system.ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species.Tissue-specific gene therapy directed to tumor angiogenesis.Suppression of WEE1 and stimulation of CDC25A correlates with endothelin-dependent proliferation of rat aortic smooth muscle cells.Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle.
P2860
Q28216230-811806A4-8FF5-452E-81CB-358BCC29B51DQ28345542-DD38F8AF-25DD-4479-A989-0F888EF87E8AQ28564825-5FFD300E-C9A3-4F73-8E76-5A4E6696B3BFQ28756314-1B673A6E-FBB3-4655-BB5F-0A1C788181CDQ34275313-C7266D9B-413E-43B2-AB74-F681339741C8Q34359362-20F2EAF7-2A47-4DAA-B931-DC168B4D1F3CQ34544685-95ADC881-DA1E-4132-BF24-E26A4A44D223Q34551567-6A43F602-3A2D-4AF8-95D6-60228C41A987Q34981727-61BD962A-F731-4D8F-9A07-B7601AEF81F9Q35074833-47BE6863-EFBA-4898-ABD4-CC091E9106F6Q35549761-0FB1EB1E-2E57-4782-B6A3-DDACF3FB813DQ35631333-C48C5032-665B-4FCB-9FF3-0D252D809B1DQ35671628-AACB9861-5E6E-4518-9366-38B67061605BQ35762215-45391DD7-8A9B-471C-B1E4-0F89632116EEQ35815897-1B3ED31F-BD81-468F-A1EF-DA6D802DF2A4Q36509251-6F98458F-3C86-4836-8C7E-4CFE6FF75098Q36516814-4419D1C1-D9F2-4C59-8E38-4C8C7DDC6CC3Q36764714-04BBAB6A-E297-42F2-8300-EB0E2A89E248Q36832901-17DBFD4C-EFA6-480E-B3C4-A264D113B6A1Q36994099-AFB29651-909A-4EC2-8C82-BC303CB8E6CAQ37027838-3BE1809A-3DD8-4AA9-A76F-A6F6B9FA4A29Q37029658-62B7A586-7394-4EB4-AECB-4004A14F0D76Q37515708-F7904D2D-1FA7-4EE5-8BC9-6C02BB84BD25Q37595494-77F9C312-FDC2-4FA2-A364-A7EDD68E14D4Q37605801-4AA43375-B2A9-44B2-BDDA-8CAE445E0C94Q37775819-59E15A11-4899-4C1F-A058-BFC1A5FFF18DQ37867668-AAB20CFA-9A89-4FDA-BA0E-4D5F30E2F55AQ37983344-4A11B1E1-417D-44EF-961C-7920AC200EDDQ38897552-B72A11A2-DE4E-4BD4-BEBF-10EB4F46EE61Q39995050-52B6BDE5-E1CA-4154-ADB7-5B6318EACF06Q40774080-EE56D059-A2E9-4D01-B759-79D3A97F9E5EQ40785888-9B2E7A68-A0E1-4399-AC7F-1C33B9983697Q40919790-531B3B3C-A894-4EC4-B708-44965B7F66C6Q41775285-535A96AA-38CA-41A8-A5C7-E401DA98DB98Q43018483-BA8F1780-F23C-4114-B8EC-0C889F941488Q43764530-12C8BA52-D60A-48EA-90D5-9BD12D396D61Q45878125-3EE65232-CD32-4726-9FEF-29039D0EEF84Q46081508-4670EB89-5142-4D66-B5C9-74DEF23FFBF9Q46424042-F5C56ACF-4A12-4EA7-8A16-39E63354388CQ46876766-166C356D-0C37-4788-B0EB-00A29D8190BD
P2860
Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@ast
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en-gb
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@nl
type
label
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@ast
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en-gb
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@nl
prefLabel
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@ast
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en-gb
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@nl
P2093
P356
P1433
P1476
Endothelin-1 potentiates human ...... ETA and ETB receptor blockade
@en
P2093
P356
10.1161/01.CIR.100.1.5
P407
P577
1999-07-06T00:00:00Z